# FDA 483 - LifeSouth Community Blood Centers, Inc - February 07, 2024

Source: https://www.keypedia.com/records/483/lifesouth-community-blood-centers-inc/e4ed943e-2ec8-411e-a8e7-49683f385fe5

> FDA 483 for LifeSouth Community Blood Centers, Inc on February 07, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: LifeSouth Community Blood Centers, Inc
- Inspection Date: 2024-02-07
- Product Type: biologics
- Office Name: Atlanta District Office
- Summary: An FDA inspection of LifeSouth Community Blood Centers, Inc. in Gainesville, GA, identified two significant observations during a mobile blood drive. The inspection revealed deficiencies in equipment calibration for blood collection and processing, as well as inadequate privacy measures during donor screening and physical examinations. These conditions indicate potential risks to the accuracy of donor eligibility determinations and the quality of collected blood components.

## Related Officers

- [Christopher J. Adams](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/7aef44ce-2ddf-48c3-a3da-9e7422f9ac29

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7